S*BIO
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma | Phase 2 | 2010-12-01 |
| Completed | A Single and Multiple-Dose Study of SB1578 Healthy Volunteer | Phase 1 | 2010-08-01 |
| Completed | A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis Myelofibrosis, Myeloproliferative Disorders, Polycythemia Vera | Phase 1 / Phase 2 | 2008-08-01 |
| Completed | A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia | Phase 1 / Phase 2 | 2008-08-01 |
| Completed | A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies Lymphoma, Malignant, Hodgkin's Lymphoma, B Cell Lymphoma | Phase 1 | 2008-07-01 |
| Completed | A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine Solid Tumors, Hematologic Malignancies, Myelodysplastic Syndrome | Phase 1 | 2007-04-01 |